PJ, 22/29 November 2014, Vol 293, No 7837/8

RPS disputes NICE appraisal of pharmacist medication reviews

Proposed guideline says pharmacist medication reviews do not provide value for money for the NHS.…

Not all NHS waste is wasteful

Amidst the drive for efficiency in the NHS, medicines waste must not be oversimplified.…

Q&A: Failure to cap student numbers risks poorer job prospects

David Branford, English Pharmacy Board chairman, says the government’s decision not to cap pharmacy student numbers could lower the quality of applicants and lead to greater unemployment levels.…

Exploring the history of generic medicines

‘Generic: the unbranding of modern medicine’ by Jeremy A Greene.…

Medicinal cannabis: time for a comeback?

The stringent laws on cannabis do no favours for patients, clinicians and researchers.…

Selective COX-2 inhibitors linked to worse outcomes after ischaemic stroke

New research suggests that selective cyclooxygenase-2 inhibitors herald worse outcomes following ischaemic stroke.…

Patient’s own glioblastoma cells used to treat tumour

Hopes for a vaccine to tackle glioblastoma are bolstered by positive results from a phase I trial reported in Cancer Immunology and Immunotherapy.…

Role for memantine in treating binge-eating disorder

Research findings support a role for memantine as a potential pharmacological treatment for binge-eating disorder.…

Acute and long-term management of bipolar disorder

How the latest NICE guidelines affect the recommended treatments for this complex mental health condition.…

Immune checkpoint inhibitors bring new hope to cancer patients

PD-1 and PD-L1 inhibitors induce a higher response rate across a wider range of tumours than other immunotherapies.…